Next Article in Journal
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
Next Article in Special Issue
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Previous Article in Journal
Pharmacokinetic Interaction Between Olaparib and Regorafenib in an Animal Model
Previous Article in Special Issue
Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1576; https://doi.org/10.3390/pharmaceutics16121576
Action Date Notes Link
article xml file uploaded 10 December 2024 10:16 CET Original file -
article xml uploaded. 10 December 2024 10:16 CET Update https://www.mdpi.com/1999-4923/16/12/1576/xml
article pdf uploaded. 10 December 2024 10:16 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1576/pdf
article supplementary file uploaded. 10 December 2024 10:16 CET - https://www.mdpi.com/1999-4923/16/12/1576#supplementary
article html file updated 10 December 2024 10:18 CET Original file https://www.mdpi.com/1999-4923/16/12/1576/html
Back to TopTop